Pulse Biosciences (PLSE)
NASDAQ:PLSE

Pulse Biosciences (PLSE) Stock Price & Analysis

174 Followers

PLSE Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.65 - $9.69
Previous Close$4.42
Volume79.63K
Average Volume (3M)185.95K
Market Cap
$242.67M
Enterprise Value$193.54M
Total Cash (Recent Filing)$58.75M
Total Debt (Recent Filing)$9.62M
Price to Earnings (P/E)-3.6
Beta0.97
Nov 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.22
Shares Outstanding54,902,942
10 Day Avg. Volume100,149
30 Day Avg. Volume185,954
Standard Deviation0.28
R-Squared0.06
Alpha0.00618
Financial Highlights & Ratios
Price to Book (P/B)4.02
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-5.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-21.50K
Enterprise Value/Gross Profit-17.21
Enterprise Value/Ebitda-4.28
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

PLSE FAQ

What was Pulse Biosciences’s price range in the past 12 months?
Pulse Biosciences lowest stock price was $1.65 and its highest was $9.69 in the past 12 months.
    What is Pulse Biosciences’s market cap?
    Currently, no data Available
    When is Pulse Biosciences’s upcoming earnings report date?
    Pulse Biosciences’s upcoming earnings report date is Nov 09, 2023 which is in 21 days.
      How were Pulse Biosciences’s earnings last quarter?
      Pulse Biosciences released its earnings results on Aug 10, 2023. The company reported -$0.22 earnings per share for the quarter, beating the consensus estimate of -$0.24 by $0.02.
        Is Pulse Biosciences overvalued?
        According to Wall Street analysts Pulse Biosciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Pulse Biosciences pay dividends?
          Pulse Biosciences does not currently pay dividends.
          What is Pulse Biosciences’s EPS estimate?
          Pulse Biosciences’s EPS estimate is -$0.24.
            How many shares outstanding does Pulse Biosciences have?
            Pulse Biosciences has 54,902,943 shares outstanding.
              What happened to Pulse Biosciences’s price movement after its last earnings report?
              Pulse Biosciences reported an EPS of -$0.22 in its last earnings report, beating expectations of -$0.24. Following the earnings report the stock price went up 5.556%.
                Which hedge fund is a major shareholder of Pulse Biosciences?
                Among the largest hedge funds holding Pulse Biosciences’s share is Robert Bender&Associates. It holds Pulse Biosciences’s shares valued at 74K.

                  ---

                  Pulse Biosciences Stock Smart Score

                  The Pulse Biosciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Pulse Biosciences

                  Pulse Biosciences, Inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary Nano-Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.

                  ---

                  Top 5 ETFs holding PLSE

                  Name
                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  $70.24K
                  8
                  Vanguard Russell 3000 ETF
                  $4.50K
                  8
                  Up to five ETFs with an Outperform Smart Score that hold PLSE. The ETFs are listed according to market value of PLSE within the ETF

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Durect
                  Galectin Therapeutics
                  Arrowhead Pharmaceuticals
                  Corbus Pharmaceuticals

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis